Pheophorbide A
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Pheophorbide A
Description:
Pheophorbide A is an intermediate product in the chlorophyll degradation pathway. Pheophorbide A can be used as a photosensitizer. Pheophorbide A is a lymphatic vascular activator. Pheophorbide A has antitumor activity. Pheophorbide A can be used for human lymphatic vascular insufficiencies research[1][2][3].UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
ApoptosisType:
Natural ProductsRelated Pathways:
ApoptosisApplications:
Cancer-programmed cell deathField of Research:
Cancer; Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/pheophorbide-a.htmlPurity:
95.0Solubility:
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
O=C ([C@@H]1/C (C (NC (/C=C2C (CC) =C3C) =C4C) =C4C1=O) =C (N=C (/C=C (C (C) =C/5C=C) \NC5=C/C3=N/2) [C@H]6C) \[C@H]6CCC (O) =O) OCMolecular Formula:
C35H36N4O5Molecular Weight:
592.68Precautions:
H302, H315, H319, H335References & Citations:
[1]Jihye Kim, et al. Pheophorbide a identified in an Eupatorium perfoliatum extract is a novel lymphatic vascular activator. Biomed Pharmacother. 2022 Mar;147:112664.|[2]Tang PM, et al. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther. 2006 Sep;5 (9) :1111-6.|[3]Ahn MY, et al. Pheophorbide a-mediated photodynamic therapy induces apoptotic cell death in murine oral squamous cell carcinoma in vitro and in vivo. Oncol Rep. 2012 Jun;27 (6) :1772-8.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedCAS Number:
15664-29-6
